Basic Information
ProQuad
Regulatory Information
EMEA/H/C/000622
April 5, 2006
33
July 25, 2024
Company Information
Netherlands
Waarderweg 39 2031 BN Haarlem
Merck Sharp & Dohme BV
Active Substances Detail
virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication ProQuad is indicated for simultaneous vaccination against measles, mumps, rubella and varicella in individuals from 12 months of age. ProQuad can be administered to individuals from 9 months of age under special circumstances (e.g., to conform with national vaccination schedules, outbreak situations, or travel to a region with high prevalence of measles.
Overview Summary
ProQuad is a vaccine against measles, mumps, rubella, and varicella (chickenpox). ProQuad is given to children from 12 months of age to help protect them against measles, mumps, rubella, and chickenpox. ProQuad may also be given to children from 9 months of age in certain situations, for example as part of a national vaccination programme, during an outbreak or for travel to a region where measles is common.